Risk of Osteoporotic Fracture in a Large Population-based Cohort of Patients with Rheumatoid Arthritis

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2010 Aug 5

PMID 20682035

Citations 95

Authors

Seo Young Kim

Sebastian Schneeweiss

Jun Liu

Gregory W Daniel

Chun-Lan Chang

Katie Garneau

Daniel H Solomon

Affiliations

Soon will be listed here.

Abstract

Introduction: Although osteoporosis has been reported to be more common in patients with rheumatoid arthritis (RA), little is known whether the risk of osteoporotic fractures in these patients differs by age, sex, and anatomic site.

Methods: A retrospective cohort study was conducted using a health care utilization database. Incidence rates (IRs) and rate ratios (RRs) of osteoporotic fractures with 95% confidence intervals (CIs) were calculated. Multivariable Cox proportional hazards models compared the risk of osteoporotic fracture at typical sites between RA and non-RA patients.

Results: During a median 1.63-year follow-up, 872 (1.9%) of 47,034 RA patients experienced a fracture. The IR for osteoporotic fracture at typical sites among RA patients was 9.6 per 1,000 person-years, 1.5 times higher than the rate of non-RA patients. The IR was highest for hip fracture (3.4 per 1,000 person-years) in RA. The IRs across all age groups were higher for women than men and increased with older age in both groups. The RRs were elevated in RA patients across all common sites of osteoporotic fracture: hip (1.62, 95% CI 1.43 to 1.84), wrist (1.15, 95% CI 1.00 to 1.32), pelvis (2.02, 95% CI 1.77 to 2.30), and humerus (1.51, 95% CI 1.27 to 1.84). After confounding adjustment, a modest increase in risk for fracture was noted with RA (hazard ratio 1.26, 95% CI 1.15 to 1.38).

Conclusions: Our study showed an increased risk of osteoporotic fractures for RA patients across all age groups, sex and various anatomic sites, compared with non-RA patients.

Citing Articles

First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities.

Taylor-Williams O, Keen H, Preen D, Nossent J, Inderjeeth C Osteoporos Int. 2024; 36(1):113-121.

PMID: 39532717 DOI: 10.1007/s00198-024-07311-1.

Identification of key genes and long non‑coding RNA expression profiles in osteoporosis with rheumatoid arthritis based on bioinformatics analysis.

An J, Ma X, Wen H, Hu H BMC Musculoskelet Disord. 2024; 25(1):634.

PMID: 39118036 PMC: 11312199. DOI: 10.1186/s12891-024-07738-x.

Application of two-sample Mendelian randomization method to assess the causal relationship between rheumatoid arthritis and osteoporotic fracture.

Zhenyu C, Le C, Shiyong Z, Jinding L, Mingzhong L, Haifeng T Front Med (Lausanne). 2024; 11:1388968.

PMID: 38799148 PMC: 11116583. DOI: 10.3389/fmed.2024.1388968.

Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis.

Yang M, Zhu L Int J Mol Sci. 2024; 25(5).

PMID: 38473934 PMC: 10931770. DOI: 10.3390/ijms25052688.

Pain score as a predictor of subsequent fragility fracture in postmenopausal patients with rheumatoid arthritis: A retrospective case-control study.

Yoshii I, Sawada N, Chijiwa T Osteoporos Sarcopenia. 2024; 9(4):150-156.

PMID: 38374825 PMC: 10874728. DOI: 10.1016/j.afos.2023.12.001.

References

Needham D, Scales D, Laupacis A, Pronovost P . A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005; 20(1):12-9. DOI: 10.1016/j.jcrc.2004.09.007. View

Deyo R, Cherkin D, Ciol M . Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45(6):613-9. DOI: 10.1016/0895-4356(92)90133-8. View

Koh J, Khang Y, Jung C, Bae S, Kim D, Chung Y . Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005; 16(10):1263-71. DOI: 10.1007/s00198-005-1840-5. View

Durward G, Non Pugh C, Ogunremi L, Wills R, Cottee M, Patel S . Detection of risk of falling and hip fracture in women referred for bone densitometry. Lancet. 1999; 354(9174):220-1. DOI: 10.1016/s0140-6736(99)01871-1. View

Kanis J, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B . Assessment of fracture risk. Osteoporos Int. 2004; 16(6):581-9. DOI: 10.1007/s00198-004-1780-5. View

Wijbrandts C, Klaasen R, Dijkgraaf M, Gerlag D, van Eck-Smit B, Tak P . Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis. 2008; 68(3):373-6. PMC: 2945478. DOI: 10.1136/ard.2008.091611. View

Cummings S, Nevitt M, Browner W, Stone K, Fox K, Ensrud K . Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332(12):767-73. DOI: 10.1056/NEJM199503233321202. View

Cauley J, Danielson M, Boudreau R, Forrest K, Zmuda J, Pahor M . Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007; 22(7):1088-95. DOI: 10.1359/jbmr.070409. View

Ray W, Griffin M, Fought R, Adams M . Identification of fractures from computerized Medicare files. J Clin Epidemiol. 1992; 45(7):703-14. DOI: 10.1016/0895-4356(92)90047-q. View

10.

Jilka R . Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone. 1998; 23(2):75-81. DOI: 10.1016/s8756-3282(98)00077-5. View

11.

Michel B, Bloch D, Wolfe F, Fries J . Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol. 1993; 20(10):1666-9. View

12.

Kanis J, McCloskey E, Johansson H, Oden A, Strom O, Borgstrom F . Development and use of FRAX in osteoporosis. Osteoporos Int. 2010; 21 Suppl 2:S407-13. DOI: 10.1007/s00198-010-1253-y. View

13.

Allali F, Breban M, Porcher R, Maillefert J, Dougados M, Roux C . Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis. 2003; 62(4):347-9. PMC: 1754495. DOI: 10.1136/ard.62.4.347. View

14.

Solomon D, Avorn J, Katz J, Weinblatt M, Setoguchi S, Levin R . Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 2006; 54(12):3790-8. DOI: 10.1002/art.22255. View

15.

Korczowska I, Olewicz-Gawlik A, Trefler J, Hrycaj P, Lacki J . Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?. Clin Rheumatol. 2007; 27(5):565-72. DOI: 10.1007/s10067-007-0747-2. View

16.

Barnabe C, Hanley D . Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy. Semin Arthritis Rheum. 2008; 39(2):116-22. DOI: 10.1016/j.semarthrit.2008.04.004. View

17.

de Jong Z, Munneke M, Lems W, Zwinderman A, Kroon H, Pauwels E . Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. Arthritis Rheum. 2004; 50(4):1066-76. DOI: 10.1002/art.20117. View

18.

Haugeberg G, Uhlig T, Falch J, Halse J, Kvien T . Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000; 43(3):522-30. DOI: 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y. View

19.

Coulson K, Reed G, Gilliam B, Kremer J, Pepmueller P . Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol. 2009; 15(4):155-60. DOI: 10.1097/RHU.0b013e3181a5679d. View

20.

Lane N, Pressman A, Star V, Cummings S, Nevitt M . Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1995; 10(2):257-63. DOI: 10.1002/jbmr.5650100212. View